| Literature DB >> 33129342 |
Huiyan Tian1, Changjing Yuan1, Yu Liu1, Zhi Li1, Ke Xia1, Mengya Li1, Fengxin Xie1, Qinghai Chen1, Ming Chen1, Weiling Fu2, Yang Zhang3.
Abstract
MiRNA-150, a gene regulator that has been revealed to be abnormal expression in non-small cell lung cancer (NSCLC), can be regarded as a serum indicator for diagnosis and monitoring of NSCLC. Herein, a new sort of nanoprobe, termed allosteric spherical nanoprobe, was first developed to sense miRNA-150. Compared with conventional hairpin, this new nanoprobe possesses more enrichment capacity and reaction cross section. Structurally, it consists of magnetic nanoparticles and dual-hairpin. In the absence of miRNA-150, the spherical nanoprobes form hairpin structure through DNA self-assembly, which could promote the Förster resonance energy transfer (FRET) of fluorophore (FAM) and quencher (BHQ1) nearby. However, in the presence of target, the target-probe hybridization can open the hairpin and form the active "Y" structure which separated fluorophore and quencher to yield "signal on" fluorescence. In the manner of multipoint fluorescence detection, the target-bound allosteric spherical nanoprobe could provide high detection sensitivity with a linear range of 100 fM to 10 nM and a detection limit of 38 fM. More importantly, the proposed method can distinguish the expression of serum miRNA-150 among NSCLC patients and healthy people. Finally, we hoped that the potential bioanalytical application of this nanoprobe strategy will pave the way for point-of-care testing (POCT).Entities:
Keywords: Allosteric spherical nanoprobe; Dual-hairpin; Förster resonance energy transfer (FRET); MiRNA-150; Point-of-care testing (POCT)
Mesh:
Substances:
Year: 2020 PMID: 33129342 PMCID: PMC7603675 DOI: 10.1186/s12951-020-00717-z
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 10.435
Scheme 1Schematic illustration of the allosteric spherical nanoprobe for miRNA-150 direct multipoint fluorescence detection
Fig. 1Characterization of the allosteric spherical nanoprobe. a Melting curve of allosteric spherical nanoprobe and the hybridization structure. b Non-denatured PAGE analysis of allosteric spherical nanoprobe. Lane 1, Seq A; lane 2, Seq B; lane 3, Seq C; lane 4, miRNA-150; lane 5, dual-hairpin; lane 6: dual-hairpin and miRNA-150; M1, DNA marker; M2, miRNA marker. c Fluorescence emission spectra of different sequence in allosteric spherical nanoprobe. The concentrations of samples were both 2000 nM
Fig. 2Feasibility of allosteric spherical nanoprobe assay. a Fluorescence intensity of allosteric spherical nanoprobes in the absence and presence of miRNA-150. b Fluorescence micrograph image of hairpins-modified magnetic beads. c Fluorescence micrograph image of reaction products of allosteric spherical nanoprobes and miRNA-150
Fig. 3Optimization of allosteric spherical nanoprobe assay. a The ratio of different components in probe (A:B:C). b The ratio of microsphere to probes. c The reaction temperature. d The concentration of Mg2+
Fig. 4Allosteric spherical nanoprobe assay performance for miRNA-150 detection. a The relative fluorescence intensity of the allosteric spherical nanoprobes with different miRNA-150 concentrations. b The linear relationship between the relative fluorescence intensity and the logarithm of miRNA-150 concentration over the range from 100 fM to 10 nM. c The results of real human serum samples for both NSCLC cancer patients (B) and healthy donors (A) with qRT-PCR (red) and the proposed method (blue). d The multipoint fluorescence scanning results on microarray corresponding to (a)
Actual and measured concentration of miRNA-150 in human serum samples
| Sample number | Added miRNA | Measured miRNA | RSD (%) (n = 6) | Recovery (%) |
|---|---|---|---|---|
| 1 | 100 pM | 104.36 pM | 6.19 | 104.36 |
| 2 | 10 pM | 10.69 pM | 2.86 | 106.9 |
| 3 | 1 pM | 0.97 pM | 6.10 | 97 |
| 4 | 100 fM | 102.11 fM | 4.00 | 102.11 |
| 5 | 10 fM | 9.27 fM | 3.90 | 92.7 |
Fig. 5Selectivity of the proposed method. Fluorescence emission spectra in response to miRNA-150, single-base mismatched miRNA-150 (miRNA-M1), three-base mismatched miRNA-150 (miRNA-M3) and a completely unrelated sequence (miRNA-P). Inset shows the multipoint fluorescence scanning results on microarray corresponding to the fluorescence emission spectra